Bruton's tyrosine kinase defect in dendritic cells from X-linked agammaglobulinaemia patients does not influence their differentiation, maturation and antigen-presenting cell function

Clinical and Experimental Immunology

Volumn 133, Issue 1, 2003, Pages 115-122

  Gagliardi, Maria Cristina ^a,c   Finocchi, A ^a   Orlandi, P ^a   Cursi, L ^a   Cancrini, C ^a   Moschese, V ^a   Miyawaki, T ^b   Rossi, P ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY OF TOYAMA   (Japan)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Dendritic cells; Maturation; T cell polarization; X linked agammaglobulinaemia

Indexed keywords

CD83 ANTIGEN; CYTOKINE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; HLA B7 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN TYROSINE KINASE; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 4;

AGAMMAGLOBULINEMIA; ANTIGEN PRESENTING CELL; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; FLUORESCENCE ACTIVATED CELL SORTING; GENETIC DISORDER; HUMAN; HUMAN CELL; MALE; MIXED LYMPHOCYTE REACTION; PRIORITY JOURNAL; X CHROMOSOME RECESSIVE DISORDER; X LINKED AGAMMAGLOBULINEMIA;

AGAMMAGLOBULINEMIA; ANTIGEN PRESENTATION; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; CASE-CONTROL STUDIES; CELL CYCLE; CELL DIFFERENTIATION; CELLS, CULTURED; CHROMOSOMES, HUMAN, X; DENDRITIC CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNOGLOBULINS; INTERLEUKIN-10; INTERLEUKIN-12; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; PROTEIN-TYROSINE KINASES; T-LYMPHOCYTES;

EID: 0038723629     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2003.t01-1-02178.x     Document Type: Article

References (33)

1. Sideras P, Smith CI. Molecular and cellular aspects of X-linked agammaglobulinemia. Adv Immunol 1995; 59:135-223.
2. Ochs HD, Smith CI. X-linked agammaglobulinemia. A clinical and molecular analysis. Medicine (Baltimore) 1996; 75:287-99.
3. Tsukada S, Saffran DC, Rawlings DJ et al. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X- linked agammaglobulinemia. Cell 1993; 72:279-90.
4. Vetrie D, Vorechovsky I, Sideras P et al. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature 1993; 361:226-33.
5. Rawlings DJ, Saffran DC, Tsukada S et al. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science 1993; 261:358-61.
6. Rosen FS, Cooper MD, Wedgwood RJ. The primary immunodeficiencies. N Engl J Med 1995; 333:431-40.
7. Timmers E, de Weers M, Alt FW, Hendriks RW, Schuurman RK. X-linked agammaglobulinemia. Clin Immunol Immunopathol 1991; 61:S83-93.
8. Tsukada S, Rawlings DJ, Witte ON. Role of Bruton's tyrosine kinase in immunodeficiency. Curr Opin Immunol 1994; 6:623-30.
9. Yamada N, Kawakami Y, Kimura H et al. Structure and expression of novel protein-tyrosine kinases, Emb and Emt, in hematopoietic cells. Biochem Biophys Res Commun 1993; 192:231-40.
10. Liao XC, Littman DR, Weiss A. Itk and Fyn make independent contributions to T cell activation. J Exp Med 1997; 186:2069-73.
11. Saharinen P, Ekman N, Sarvas K, Parker P, Alitalo K, Silvennoinen O. The Bmx tyrosine kinase induces activation of the Stat signaling pathway, which is specifically inhibited by protein kinase Cdelta. Blood 1997; 90:4341-53.
12. Weil D, Power MA, Smith SI, Li CL. Predominant expression of murine Bmx tyrosine kinase in the granulo- monocytic lineage. Blood 1997; 90:4332-40.
13. Kitanaka A, Mano H, Conley ME, Campana D. Expression and activation of the nonreceptor tyrosine kinase Tec in human B cells. Blood 1998; 91:940-8.
14. Desiderio S. Role of Btk in B cell development and signaling. Curr Opin Immunol 1997; 9:534-40.
15. Khan WN, Sideras P, Rosen FS, Alt FW. The role of Bruton's tyrosine kinase in B-cell development and function in mice and man. Ann N Y Acad Sci 1995; 764:27-38.
16. Khan WN, Alt FW, Gerstein RM et al. Defective B cell development and function in Btk-deficient mice. Immunity 1995; 3:283-99.
17. Sato S, Katagiri T, Takaki S et al. IL-5 receptor-mediated tyrosine phosphorylation of SH2/SH3-containing proteins and activation of Bruton's tyrosine and Janus 2 kinases. J Exp Med 1994; 180:2101-11.
18. Matsuda T, Takahashi-Tezuka M, Fukada T et al. Association and activation of Btk and Tec tyrosine kinases by gp130, a signal transducer of the interleukin-6 family of cytokines. Blood 1995; 85:627-33.
19. Hata D, Kawakami Y, Inagaki N et al. Involvement of Bruton's tyrosine kinase in FcepsilonRI-dependent mast cell degranulation and cytokine production. J Exp Med 1998; 187:1235-47.
20. Mukhopadhyay S, George A, Bal V, Ravindran B, Rath S. Bruton's tyrosine kinase deficiency in macrophages inhibits nitric oxide generation leading to enhancement of IL-12 induction. J Immunol 1999; 163:1786-92.
21. Mukhopadhyay S, Sahoo PK, George A, Bal V, Rath S, Ravindran B. Delayed clearance of filarial infection and enhancedTh1 immunity due to modulation of macrophage APC functions in xid mice. J Immunol 1999; 163:875-83.
22. Banchereau J, Briere F, Caux C et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18:767-811.
23. Moser M, Murphy KM. Dendritic cell regulation of TH1-TH2 development. Nat Immunol 2000; 1:199-205.
24. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392:245-52.
25. Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 1995; 182:389-400.
26. Moschese V, Orlandi P, Plebani A et al. X-chromosome inactivation and mutation pattern in the Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinemia. Italian XLA Collaborative Group. Mol Med 2000; 6:104-13.
27. Futatani T, Miyawaki T, Tsukada S et al. Deficient expression of Bruton's tyrosine kinase in monocytes from X- linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection. Blood 1998; 91:595-602.
28. Conley ME, Puck JM. Carrier detection in typical and atypical X-linked agammaglobulinemia. J Pediatr 1988; 112:688-94.
29. Puck JM, Nussbaum RL, Conley ME. Carrier detection in X-linked severe combined immunodeficiency based on patterns of X chromosome inactivation. J Clin Invest 1987; 79:1395-400.
30. Cella M, Salio M, Sakakibara Y, Langen H, Julkunen I, Lanzavecchia A. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J Exp Med 1999; 189:821-9.
31. Corinti S, Albanesi C, la Sala A, Pastore S, Girolomoni G. Regulatory activity of autocrine IL-10 on dendritic cell functions. J Immunol 2001; 166:4312-8.
32. Paroli M, Accapezzato D, Francavilla V et al. Long-lasting memory-resting and memory-effector CD4+ T cells in human X- linked agammaglobulinemia. Blood 2002; 99:2131-7.
33. Amedei A, Romagnani C, Benagiano M et al. Preferential Th1 profile of T helper cell responses in X-linked (Bruton's) agammaglobulinemia. Eur J Immunol 2001; 31:1927-34.